The leading cannabis producer Aurora Cannabis In, announced the acquisition of Reliva, LLC, a leader in the sale of hemp-derived CBD products in the United States.
- The transaction will combine Aurora’s leading Canadian recreational brands, and Canadian and European medical market position with the leading U.S. hemp-derived CBD brand in retail stores.
- The transaction is expected to close, subject to customary closing conditions, in June 2020.
- It is anticipated that the transaction will be immediately accretive to Aurora on an Adjusted EBITDA basis, consistent with Aurora’s objective to drive towards Adjusted EBITDA profitability in its fiscal first quarter of 2021.
- In November 2019, Aurora Cannabis Inc. announced the grand opening of its flagship retail store in the West Edmonton Mall, North America’s largest mall. At approximately 11,000 square feet, Aurora has combined both a retail cannabis store and an immersive experiential space, encouraging visitors from around the world to explore unique products and participate in a rotating calendar of programming and events.
About Aurora Cannabis
Aurora Cannabis, headquartered in Edmonton, Alberta, Canada, is a leading integrated cannabis company. It is one of the worlds largest cannabis product producers. The company has operations in more than 25 countries across the globe. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.